RecruitingNot Applicable

MARPE-Associated Changes in Sleep and Airway

Turkey (Türkiye)40 participantsStarted 2025-05-30

Plain-language summary

At the beginning of MARPE treatment (T1) and at the end of the 3-month consolidation phase (T2), patients will complete the teen-STOP-BANG questionnaire and the Pittsburgh Sleep Quality Index (PSQI) to assess the potential benefit of MARPE in reducing the risk of obstructive sleep apnea syndrome (OSAS). Additionally, changes in the upper airway will be evaluated using CBCT images obtained at T1 and T2.

Who can participate

Age range15 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Class I malocclusion Maxillary transverse deficiency Age between 15 and 18 years No systemic disease, cleft lip and palate, or speech disorders No history of prior orthodontic treatment Voluntary agreement to participate in the study Good oral hygiene ANB angle between 2° and 5° Exclusion Criteria: Presence of systemic diseases Smoking Poor oral hygiene Lack of cooperation Mental retardation Obesity or nutritional disorders Macroglossia or mandibular retrognathia

What they're measuring

Change in obstructive sleep apnea (OSA) risk as measured by the teen-STOP-BANG questionnaire

Timeframe: 3 month

Trial details

NCT IDNCT07031349

SponsorKonya Necmettin Erbakan Üniversitesi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-30

Contact for this trial

Seda Sağoğlu

+905354121271 ssagoglu@gmail.com

View on ClinicalTrials.gov More Rapid Maxillary Expansion trials